Smith, G.D., Payne, N., Pickin, M., Sheldon, T.A., Lampe, F., Sampson, F., Wannamthee, G., Ebrahim, S., McCabe, C. and Ward, S. (1998) Cholesterol and coronary heart disease: screening and treatment. Quality in Health Care. pp. 232-239. ISSN 0963-8172Full text available as:
Coronary heart disease (CHD) is a major cause of morbidity and mortality in the United Kingdom, accounting for just under one quarter of all deaths in 1995: 27% among men and 21% among women.1 Although many CHD deaths occur among elderly people, CHD accounts for 31% of male and 13% of female deaths within the 45–64 age group.
|Keywords:||SCANDINAVIAN SIMVASTATIN SURVIVAL, GENERAL-PRACTICE, MYOCARDIAL-INFARCTION, COST-EFFECTIVENESS, SECONDARY PREVENTION, BLOOD CHOLESTEROL, PHYSICAL-ACTIVITY, CONTROLLED TRIAL, DRUG-TREATMENT, SERUM-LIPIDS|
|Institution:||The University of York|
|Depositing User:||Sherpa Assistant|
|Date Deposited:||30 Jan 2006|
|Last Modified:||14 Oct 2014 11:45|